- Floxuridine
drugbox
IUPAC_name = 5-Fluoro-1- [4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl] -1H-pyrimidine-2,4-dione
CAS_number = 50-91-9
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 5790
DrugBank = APRD00692
C=9 | H=11 | F=1 | N=2 | O=5
molecular_weight = 246.193 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
pregnancy_category =
legal_status =
routes_of_administration =Floxuridine is an
oncology drug that belongs to the class known asantimetabolite s. The drug is most often used in the treatment of colorectal cancer.Pharmacology
Floxuridine, an analog of 5-
fluorouracil , is a fluorinatedpyrimidine .Meachanism of action
Floxuridine works because it is broken down by the body into its active form, which is the same as a metabolite of 5-Fluorouracil.
History
Floxuridine first gained FDA approval in December 1970 under the brand name FUDR. The drug was initially marketed by Roche, which also did a lot of the initial work on 5-fluorouracil. The
National Cancer Institute was an early developer of the drug. Roche sold its FUDR product line in 2001 to Faulding, which became Mayne Pharma.uppliers
In the US the drug is supplied by APP Pharmaceuticals, LLC; Hospira, Inc.; and Bedford Laboratories.
Wikimedia Foundation. 2010.